-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against IronNet, Inc. (IRNT) f/k/a LGL Systems Acquisition Corp.

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors of a class action on behalf of all persons and entities that purchased or otherwise acquired IronNet, Inc. (NYSE: IRNT) f/k/a LGL Systems Acquisition Corp. securities between September 15, 2021 and December 15, 2021, for violations of the Securities Exchange Act of 1934. IronNet designs and develops solutions for the prevention of cyber attacks.

If you would like more information about IronNet Inc.'s misconduct, click here.

What is this Case About: IronNet, Inc. (IRNT) Misrepresented its Business and Financial Prospects

According to the complaint, on August 27, 2021, IronNet became a publicly traded company via merger with LGL Systems Acquisition Corp. IronNet's financial projects, which shareholders relied upon in voting for the merger, forecasted fiscal year 2022 revenues of $43 million to $45 million and annual recurring revenue ("ARR") of $75 million.

On September 14, 2021, IronNet announced disappointing second quarter 2022 financial results of $6.1 million for Q2 2022 compared to $7.9 million for Q2 2021 and a net loss of $17.2 million. Notwithstanding, IronNet affirmed its projections and assured investors it was "on target with our first half guidance." The result was a 38% increase in the stock price and a closing stock price of $32.13 per share.

However, by December 15, 2021, the Company splashed its expected fiscal year 2022 revenue to just $26 million with ARR of approximately $30 million. The Company also announced it had terminated its Chief Revenue Officer. On this news, IronNet's stock fell 31% to close at $4.66 per share on December 15, 2021.

During the class period, IronNet materially overstated its business and financial prospects. Specifically, the Company was unable to predict the timing of significant customer opportunities, which constituted a substantial portion of its publicly-issued FY 2022 financial guidance.

Next Steps: If you acquired shares of IronNet, Inc. (IRNT) between September 15, 2021 and December 15, 2021, you have until June 21, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against IronNet, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:IRNT

Release Summary
IronNet, Inc. (IRNT) Misrepresented its Business and Financial Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Masonite International Corporation (k/n/a Owens Corning's Doors) Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and re...
Back to Newsroom